Realizing the impact of the ISR on cancer patients, researchers now suggest that stress markers P-eIF2α and PKR can be used as biomarkers to identify cancers with increased cellular stress and as a tool for patient prognosis [122,123,124]. Here, EIF2A is linked to cancer.